Quality of life should be the primary outcome for disease modifying therapy trials in MS—No

por Strijbis, EMM, Koch, MW, de Jong, BA
Publicado 2023

Autoantibodies predict progression to rheumatoid arthritis in undifferentiated arthritis: a prospective cohort study

por van Gaalen, FA, Linn-Rasker, SP, van Venrooij, WJ, de Jong, BA, Breedveld, FC, Verweij, CL, Toes, REM, Huizinga, TWJ
Publicado 2003

Reliability, construct and concurrent validity of a smartphone-based cognition test in multiple sclerosis

por Lam, KH, van Oirschot, P, den Teuling, B, Hulst, HE, de Jong, BA, Uitdehaag, BMJ, de Groot, V, Killestein, J
Publicado 2021

Performance validity in outpatients with multiple sclerosis and cognitive complaints

por Nauta, IM, Bertens, D, van Dam, M, Huiskamp, M, Driessen, S, Geurts, JJG, Uitdehaag, BMJ, Fasotti, L, Hulst, HE, de Jong, BA, Klein, M
Publicado 2021